March 16, 2026
Projections indicate that, infectious diseases industry is projected to rise from USD 23 billion in 2025 to USD 40.42 billion by 2035, reflecting a CAGR of 5.8% over the next decade. The continuous emergence of various pathogens, resulting in persist...
April 21, 2026
According to market projections, the U.S. point-of-care infectious disease testing market, valued at USD 2.1 billion in 2024, is anticipated to reach USD 5.01 billion by 2034, growing at a CAGR of 9.34% over the next decade. The expanding growth of p...
January 29, 2026
Based on market forecasts, the global infectious disease testing market, projected at USD 29.04 billion in 2025, is expected to reach USD 53.19 billion by 2035, growing at a CAGR of 6.24% over the forecast period. The infectious disease testing marke...
April 21, 2026
Market insights predict, the veterinary infectious disease diagnostics industry is expected to grow from USD 2.68 billion in 2024 to USD 5.76 billion by 2034, driven by a CAGR of 7.95%.The growing infectious disease cases and awareness about animal...
April 24, 2026
Point of Care Infectious Disease Testing Market (By Technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through test/Immunoconcentration Assay, Molecular Diagnostics; Others By Disease: HIV POC, Clostridium Difficile POC, HBV POC, Pneumoni...
April 21, 2026
Market insights predict, the infectious disease diagnostics industry is expected to grow from USD 25.01 billion in 2024 to USD 62.95 billion by 2034, driven by a CAGR of 9.67%.The market is growing due to healthcare providers seeking faster, more rel...
April 21, 2026
According to market projections, the cardiometabolic diseases market was valued at USD 292.04 billion in 2026 and is projected to reach approximately USD 1,987.69 billion by 2035, growing at a strong CAGR of 23.75% from 2026 to 2035. The cardiometabo...
April 21, 2026
Based on market forecasts, the targeted drugs for allergic diseases sector will expand from USD 13.96 billion in 2024 to USD 30.22 billion by 2034, experiencing a CAGR of 8.06%. The targeted drugs for allergic diseases market is growing due to rising...
April 09, 2026
Biomarkers Market (By Type: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers; By Disease: Cancer, Neurological Diseases, Immunological Diseases, Cardiovascular Diseases, Others; By Application: Drug Discovery & Development, Personali...
April 21, 2026
Market insights predict, the metagenomic sequencing industry is expected to grow from USD 2.24 billion in 2024 to USD 7.63 billion by 2034, driven by a CAGR of 13.04%. The rising prevalence of genetic and infectious disorders and the growing demand f...
March 13, 2026
According to market projections, the pacemeter sector is expected to grow from USD 5.65 billion in 2025 to USD 8.17 billion by 2035, reflecting a CAGR of 3.75%.The market is growing due to rising incidence of cardiac disorders an aging population. Te...
April 21, 2026
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
April 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
April 09, 2026
Smart Drug Delivery Systems Market (By Product Type: Inhalers, Smart Injectable Devices, Smart Infusion Pumps, Connected Drug Delivery Devices, Implantable Drug Delivery Systems, Transdermal Drug Delivery Systems; By Technology: IoT-based Systems, Bl...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com